Report Overview
Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (the muscles that connect to your bones and contract to allow body movement in the arms and legs, and allow for breathing).
The global Myasthenia Gravis market size was estimated at USD 1185 million in 2023 and is projected to reach USD 2071.06 million by 2032, exhibiting a CAGR of 6.40% during the forecast period.
North America Myasthenia Gravis market size was estimated at USD 343.58 million in 2023, at a CAGR of 5.49% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Myasthenia Gravis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Myasthenia Gravis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Myasthenia Gravis market in any manner.
Global Myasthenia Gravis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Roche
CSL Limited
Baxter International
Novartis
Bausch Health
Grifols
AstraZeneca
Avadel Pharmaceuticals
Octapharma
Astellas Pharma
Zydus Lifesciences
Kedrion S.p.A.
Market Segmentation (by Type)
Monoclonal Antibodies
Intravenous Immunoglobulin
Others
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Myasthenia Gravis Market
Overview of the regional outlook of the Myasthenia Gravis Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Myasthenia Gravis
1.2 Key Market Segments
1.2.1 Myasthenia Gravis Segment by Type
1.2.2 Myasthenia Gravis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Myasthenia Gravis Market Overview
2.1 Global Market Overview
2.1.1 Global Myasthenia Gravis Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Myasthenia Gravis Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Myasthenia Gravis Market Competitive Landscape
3.1 Global Myasthenia Gravis Sales by Manufacturers (2019-2025)
3.2 Global Myasthenia Gravis Revenue Market Share by Manufacturers (2019-2025)
3.3 Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Myasthenia Gravis Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Myasthenia Gravis Sales Sites, Area Served, Product Type
3.6 Myasthenia Gravis Market Competitive Situation and Trends
3.6.1 Myasthenia Gravis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Myasthenia Gravis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Myasthenia Gravis Industry Chain Analysis
4.1 Myasthenia Gravis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Myasthenia Gravis Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Myasthenia Gravis Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Myasthenia Gravis Sales Market Share by Type (2019-2025)
6.3 Global Myasthenia Gravis Market Size Market Share by Type (2019-2025)
6.4 Global Myasthenia Gravis Price by Type (2019-2025)
7 Myasthenia Gravis Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Myasthenia Gravis Market Sales by Application (2019-2025)
7.3 Global Myasthenia Gravis Market Size (M USD) by Application (2019-2025)
7.4 Global Myasthenia Gravis Sales Growth Rate by Application (2019-2025)
8 Myasthenia Gravis Market Consumption by Region
8.1 Global Myasthenia Gravis Sales by Region
8.1.1 Global Myasthenia Gravis Sales by Region
8.1.2 Global Myasthenia Gravis Sales Market Share by Region
8.2 North America
8.2.1 North America Myasthenia Gravis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Myasthenia Gravis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Myasthenia Gravis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Myasthenia Gravis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Myasthenia Gravis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Myasthenia Gravis Market Production by Region
9.1 Global Production of Myasthenia Gravis by Region (2019-2025)
9.2 Global Myasthenia Gravis Revenue Market Share by Region (2019-2025)
9.3 Global Myasthenia Gravis Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Myasthenia Gravis Production
9.4.1 North America Myasthenia Gravis Production Growth Rate (2019-2025)
9.4.2 North America Myasthenia Gravis Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Myasthenia Gravis Production
9.5.1 Europe Myasthenia Gravis Production Growth Rate (2019-2025)
9.5.2 Europe Myasthenia Gravis Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Myasthenia Gravis Production (2019-2025)
9.6.1 Japan Myasthenia Gravis Production Growth Rate (2019-2025)
9.6.2 Japan Myasthenia Gravis Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Myasthenia Gravis Production (2019-2025)
9.7.1 China Myasthenia Gravis Production Growth Rate (2019-2025)
9.7.2 China Myasthenia Gravis Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Takeda
10.1.1 Takeda Myasthenia Gravis Basic Information
10.1.2 Takeda Myasthenia Gravis Product Overview
10.1.3 Takeda Myasthenia Gravis Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda Myasthenia Gravis SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 Roche
10.2.1 Roche Myasthenia Gravis Basic Information
10.2.2 Roche Myasthenia Gravis Product Overview
10.2.3 Roche Myasthenia Gravis Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Myasthenia Gravis SWOT Analysis
10.2.6 Roche Recent Developments
10.3 CSL Limited
10.3.1 CSL Limited Myasthenia Gravis Basic Information
10.3.2 CSL Limited Myasthenia Gravis Product Overview
10.3.3 CSL Limited Myasthenia Gravis Product Market Performance
10.3.4 CSL Limited Myasthenia Gravis SWOT Analysis
10.3.5 CSL Limited Business Overview
10.3.6 CSL Limited Recent Developments
10.4 Baxter International
10.4.1 Baxter International Myasthenia Gravis Basic Information
10.4.2 Baxter International Myasthenia Gravis Product Overview
10.4.3 Baxter International Myasthenia Gravis Product Market Performance
10.4.4 Baxter International Business Overview
10.4.5 Baxter International Recent Developments
10.5 Novartis
10.5.1 Novartis Myasthenia Gravis Basic Information
10.5.2 Novartis Myasthenia Gravis Product Overview
10.5.3 Novartis Myasthenia Gravis Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Bausch Health
10.6.1 Bausch Health Myasthenia Gravis Basic Information
10.6.2 Bausch Health Myasthenia Gravis Product Overview
10.6.3 Bausch Health Myasthenia Gravis Product Market Performance
10.6.4 Bausch Health Business Overview
10.6.5 Bausch Health Recent Developments
10.7 Grifols
10.7.1 Grifols Myasthenia Gravis Basic Information
10.7.2 Grifols Myasthenia Gravis Product Overview
10.7.3 Grifols Myasthenia Gravis Product Market Performance
10.7.4 Grifols Business Overview
10.7.5 Grifols Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Myasthenia Gravis Basic Information
10.8.2 AstraZeneca Myasthenia Gravis Product Overview
10.8.3 AstraZeneca Myasthenia Gravis Product Market Performance
10.8.4 AstraZeneca Business Overview
10.8.5 AstraZeneca Recent Developments
10.9 Avadel Pharmaceuticals
10.9.1 Avadel Pharmaceuticals Myasthenia Gravis Basic Information
10.9.2 Avadel Pharmaceuticals Myasthenia Gravis Product Overview
10.9.3 Avadel Pharmaceuticals Myasthenia Gravis Product Market Performance
10.9.4 Avadel Pharmaceuticals Business Overview
10.9.5 Avadel Pharmaceuticals Recent Developments
10.10 Octapharma
10.10.1 Octapharma Myasthenia Gravis Basic Information
10.10.2 Octapharma Myasthenia Gravis Product Overview
10.10.3 Octapharma Myasthenia Gravis Product Market Performance
10.10.4 Octapharma Business Overview
10.10.5 Octapharma Recent Developments
10.11 Astellas Pharma
10.11.1 Astellas Pharma Myasthenia Gravis Basic Information
10.11.2 Astellas Pharma Myasthenia Gravis Product Overview
10.11.3 Astellas Pharma Myasthenia Gravis Product Market Performance
10.11.4 Astellas Pharma Business Overview
10.11.5 Astellas Pharma Recent Developments
10.12 Zydus Lifesciences
10.12.1 Zydus Lifesciences Myasthenia Gravis Basic Information
10.12.2 Zydus Lifesciences Myasthenia Gravis Product Overview
10.12.3 Zydus Lifesciences Myasthenia Gravis Product Market Performance
10.12.4 Zydus Lifesciences Business Overview
10.12.5 Zydus Lifesciences Recent Developments
10.13 Kedrion S.p.A.
10.13.1 Kedrion S.p.A. Myasthenia Gravis Basic Information
10.13.2 Kedrion S.p.A. Myasthenia Gravis Product Overview
10.13.3 Kedrion S.p.A. Myasthenia Gravis Product Market Performance
10.13.4 Kedrion S.p.A. Business Overview
10.13.5 Kedrion S.p.A. Recent Developments
11 Myasthenia Gravis Market Forecast by Region
11.1 Global Myasthenia Gravis Market Size Forecast
11.2 Global Myasthenia Gravis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Myasthenia Gravis Market Size Forecast by Country
11.2.3 Asia Pacific Myasthenia Gravis Market Size Forecast by Region
11.2.4 South America Myasthenia Gravis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Myasthenia Gravis by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Myasthenia Gravis Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Myasthenia Gravis by Type (2025-2032)
12.1.2 Global Myasthenia Gravis Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Myasthenia Gravis by Type (2025-2032)
12.2 Global Myasthenia Gravis Market Forecast by Application (2025-2032)
12.2.1 Global Myasthenia Gravis Sales (K Units) Forecast by Application
12.2.2 Global Myasthenia Gravis Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Myasthenia Gravis Market Size Comparison by Region (M USD)
Table 5. Global Myasthenia Gravis Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Myasthenia Gravis Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Myasthenia Gravis Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Myasthenia Gravis Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)
Table 10. Global Market Myasthenia Gravis Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Myasthenia Gravis Sales Sites and Area Served
Table 12. Manufacturers Myasthenia Gravis Product Type
Table 13. Global Myasthenia Gravis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Myasthenia Gravis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Myasthenia Gravis Market Challenges
Table 22. Global Myasthenia Gravis Sales by Type (K Units)
Table 23. Global Myasthenia Gravis Market Size by Type (M USD)
Table 24. Global Myasthenia Gravis Sales (K Units) by Type (2019-2025)
Table 25. Global Myasthenia Gravis Sales Market Share by Type (2019-2025)
Table 26. Global Myasthenia Gravis Market Size (M USD) by Type (2019-2025)
Table 27. Global Myasthenia Gravis Market Size Share by Type (2019-2025)
Table 28. Global Myasthenia Gravis Price (USD/Unit) by Type (2019-2025)
Table 29. Global Myasthenia Gravis Sales (K Units) by Application
Table 30. Global Myasthenia Gravis Market Size by Application
Table 31. Global Myasthenia Gravis Sales by Application (2019-2025) & (K Units)
Table 32. Global Myasthenia Gravis Sales Market Share by Application (2019-2025)
Table 33. Global Myasthenia Gravis Sales by Application (2019-2025) & (M USD)
Table 34. Global Myasthenia Gravis Market Share by Application (2019-2025)
Table 35. Global Myasthenia Gravis Sales Growth Rate by Application (2019-2025)
Table 36. Global Myasthenia Gravis Sales by Region (2019-2025) & (K Units)
Table 37. Global Myasthenia Gravis Sales Market Share by Region (2019-2025)
Table 38. North America Myasthenia Gravis Sales by Country (2019-2025) & (K Units)
Table 39. Europe Myasthenia Gravis Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Myasthenia Gravis Sales by Region (2019-2025) & (K Units)
Table 41. South America Myasthenia Gravis Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Myasthenia Gravis Sales by Region (2019-2025) & (K Units)
Table 43. Global Myasthenia Gravis Production (K Units) by Region (2019-2025)
Table 44. Global Myasthenia Gravis Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Myasthenia Gravis Revenue Market Share by Region (2019-2025)
Table 46. Global Myasthenia Gravis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Myasthenia Gravis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Myasthenia Gravis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Myasthenia Gravis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Myasthenia Gravis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Takeda Myasthenia Gravis Basic Information
Table 52. Takeda Myasthenia Gravis Product Overview
Table 53. Takeda Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Takeda Business Overview
Table 55. Takeda Myasthenia Gravis SWOT Analysis
Table 56. Takeda Recent Developments
Table 57. Roche Myasthenia Gravis Basic Information
Table 58. Roche Myasthenia Gravis Product Overview
Table 59. Roche Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Roche Business Overview
Table 61. Roche Myasthenia Gravis SWOT Analysis
Table 62. Roche Recent Developments
Table 63. CSL Limited Myasthenia Gravis Basic Information
Table 64. CSL Limited Myasthenia Gravis Product Overview
Table 65. CSL Limited Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. CSL Limited Myasthenia Gravis SWOT Analysis
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Recent Developments
Table 69. Baxter International Myasthenia Gravis Basic Information
Table 70. Baxter International Myasthenia Gravis Product Overview
Table 71. Baxter International Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Baxter International Business Overview
Table 73. Baxter International Recent Developments
Table 74. Novartis Myasthenia Gravis Basic Information
Table 75. Novartis Myasthenia Gravis Product Overview
Table 76. Novartis Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Novartis Business Overview
Table 78. Novartis Recent Developments
Table 79. Bausch Health Myasthenia Gravis Basic Information
Table 80. Bausch Health Myasthenia Gravis Product Overview
Table 81. Bausch Health Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Bausch Health Business Overview
Table 83. Bausch Health Recent Developments
Table 84. Grifols Myasthenia Gravis Basic Information
Table 85. Grifols Myasthenia Gravis Product Overview
Table 86. Grifols Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Grifols Business Overview
Table 88. Grifols Recent Developments
Table 89. AstraZeneca Myasthenia Gravis Basic Information
Table 90. AstraZeneca Myasthenia Gravis Product Overview
Table 91. AstraZeneca Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Recent Developments
Table 94. Avadel Pharmaceuticals Myasthenia Gravis Basic Information
Table 95. Avadel Pharmaceuticals Myasthenia Gravis Product Overview
Table 96. Avadel Pharmaceuticals Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Avadel Pharmaceuticals Business Overview
Table 98. Avadel Pharmaceuticals Recent Developments
Table 99. Octapharma Myasthenia Gravis Basic Information
Table 100. Octapharma Myasthenia Gravis Product Overview
Table 101. Octapharma Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Octapharma Business Overview
Table 103. Octapharma Recent Developments
Table 104. Astellas Pharma Myasthenia Gravis Basic Information
Table 105. Astellas Pharma Myasthenia Gravis Product Overview
Table 106. Astellas Pharma Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Astellas Pharma Business Overview
Table 108. Astellas Pharma Recent Developments
Table 109. Zydus Lifesciences Myasthenia Gravis Basic Information
Table 110. Zydus Lifesciences Myasthenia Gravis Product Overview
Table 111. Zydus Lifesciences Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Zydus Lifesciences Business Overview
Table 113. Zydus Lifesciences Recent Developments
Table 114. Kedrion S.p.A. Myasthenia Gravis Basic Information
Table 115. Kedrion S.p.A. Myasthenia Gravis Product Overview
Table 116. Kedrion S.p.A. Myasthenia Gravis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Kedrion S.p.A. Business Overview
Table 118. Kedrion S.p.A. Recent Developments
Table 119. Global Myasthenia Gravis Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Myasthenia Gravis Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Myasthenia Gravis Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Myasthenia Gravis Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Myasthenia Gravis Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Myasthenia Gravis Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Myasthenia Gravis Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Myasthenia Gravis Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Myasthenia Gravis Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Myasthenia Gravis Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Myasthenia Gravis Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Myasthenia Gravis Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Myasthenia Gravis Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Myasthenia Gravis Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Myasthenia Gravis Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Myasthenia Gravis Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Myasthenia Gravis Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Myasthenia Gravis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Myasthenia Gravis Market Size (M USD), 2019-2032
Figure 5. Global Myasthenia Gravis Market Size (M USD) (2019-2032)
Figure 6. Global Myasthenia Gravis Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Myasthenia Gravis Market Size by Country (M USD)
Figure 11. Myasthenia Gravis Sales Share by Manufacturers in 2023
Figure 12. Global Myasthenia Gravis Revenue Share by Manufacturers in 2023
Figure 13. Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Myasthenia Gravis Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Myasthenia Gravis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Myasthenia Gravis Market Share by Type
Figure 18. Sales Market Share of Myasthenia Gravis by Type (2019-2025)
Figure 19. Sales Market Share of Myasthenia Gravis by Type in 2023
Figure 20. Market Size Share of Myasthenia Gravis by Type (2019-2025)
Figure 21. Market Size Market Share of Myasthenia Gravis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Myasthenia Gravis Market Share by Application
Figure 24. Global Myasthenia Gravis Sales Market Share by Application (2019-2025)
Figure 25. Global Myasthenia Gravis Sales Market Share by Application in 2023
Figure 26. Global Myasthenia Gravis Market Share by Application (2019-2025)
Figure 27. Global Myasthenia Gravis Market Share by Application in 2023
Figure 28. Global Myasthenia Gravis Sales Growth Rate by Application (2019-2025)
Figure 29. Global Myasthenia Gravis Sales Market Share by Region (2019-2025)
Figure 30. North America Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Myasthenia Gravis Sales Market Share by Country in 2023
Figure 32. U.S. Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Myasthenia Gravis Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Myasthenia Gravis Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Myasthenia Gravis Sales Market Share by Country in 2023
Figure 37. Germany Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Myasthenia Gravis Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Myasthenia Gravis Sales Market Share by Region in 2023
Figure 44. China Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Myasthenia Gravis Sales and Growth Rate (K Units)
Figure 50. South America Myasthenia Gravis Sales Market Share by Country in 2023
Figure 51. Brazil Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Myasthenia Gravis Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Myasthenia Gravis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Myasthenia Gravis Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Myasthenia Gravis Production Market Share by Region (2019-2025)
Figure 62. North America Myasthenia Gravis Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Myasthenia Gravis Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Myasthenia Gravis Production (K Units) Growth Rate (2019-2025)
Figure 65. China Myasthenia Gravis Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Myasthenia Gravis Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Myasthenia Gravis Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Myasthenia Gravis Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Myasthenia Gravis Market Share Forecast by Type (2025-2032)
Figure 70. Global Myasthenia Gravis Sales Forecast by Application (2025-2032)
Figure 71. Global Myasthenia Gravis Market Share Forecast by Application (2025-2032)
